Highlights Dominion Minerals Limited

Equities

DLM

AU0000184202

Market Closed - Australian S.E. Other stock markets 01:02:02 28/08/2023 BST			5-day change	1st Jan Change
0.032 ^AUD	-.--%		-.--%	-.--%

03-25	Dominion Minerals Limited Reports Earnings Results for the Full Year Ended December 31, 2023	CI
2023	Certain Options of Dominion Minerals Limited are subject to a Lock-Up Agreement Ending on 9-OCT-2023.	CI

Highlights

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Dominion Minerals Limited Reports Earnings Results for the Full Year Ended December 31, 2023	03-25	CI
Dominion Minerals Limited Reports Earnings Results for the Half Year Ended June 30, 2023	13/09/23	CI
Dominion Minerals Limited Reports Earnings Results for the Full Year Ended December 31, 2022	31/03/23	CI
Dominion Minerals Limited Reports Earnings Results for the Half Year Ended June 30, 2022	13/09/22	CI
Dominion Minerals Limited Reports Earnings Results for the Full Year Ended December 31, 2021	29/03/22	CI
Dominion Minerals Limited Announces Maiden Mineral Resource Estimate At Georgia Lime Project	22/02/22	CI
Dominion Minerals Secures 10-Month Extension for US Project Purchase Option; Shares Up 3%	29/12/21	MT
Dominion Minerals Limited Announces That the Drilling Program At the Georgia Lime Project in South West Georgia Has Confirmed Thick, High Calcium Limestone in All 13 Drill Holes Completed in the 2021 Drilling Program	21/12/21	CI
Dominion Minerals Limited Announces That Drilling Completed At the Georgia Lime Project, USA	14/11/21	CI
Factor Therapeutics : Completes PowerLime Acquisition; Seeks to Raise $3 Million	27/09/21	MT
Factor Therapeutics Limited (ASX : FTT) completed the acquisition of PowerLime, Inc for AUD 0.75 million.	26/09/21	CI
Reverse Split: 1 of 10	12/09/21	FA
Factor Therapeutics Limited Reports Earnings Results for the Half Year to 30 June 2021	28/07/21	CI
Factor Therapeutics Limited Announces Board Changes	20/04/21	CI
Factor Therapeutics Limited entered into a term sheet agreement to acquire PowerLime, Inc.	19/04/21	CI
Factor Therapeutics Limited Reports Earnings Results for the Year Ended December 31, 2020	23/02/21	CI
Factor Therapeutics Limited cancelled the acquisition of Global commercial rights of veterinary product portfolio of LONGMILE Veterinary PET Imaging.	17/01/21	CI
Factor Therapeutics Limited entered into a term sheet to acquire Global commercial rights of veterinary product portfolio of LONGMILE Veterinary PET Imaging for $0.05 million.	23/07/20	CI
Factor Therapeutics Limited Reports Audited Consolidated and Parent Earnings Results for the Year Ended December 31, 2019	19/02/20	CI
Factor Therapeutics Limited Announces Unaudited Consolidated Earnings Results for the Six Months Ended June 30, 2019	08/08/19	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Dominion Minerals Limited

Equities

DLM

AU0000184202

Highlights

Filters